跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMBARIX 5 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMBARIX 5 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Approved
STANDARD
IMBARIX 5 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 29, 2025
Approval ID
cae97ac299b02394
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
cae97ac299b02394
Drug Cima Aemps Name
IMBARIX 5 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Register Number
90601
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2025-09-29
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
5 mg/1,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adamed Laboratorios S.L.U.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 29, 2025
Approval ID
cae97ac299b02394
Type
Standard
Back to CIMA-AEMPS Approvals